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Little is known about sex difference of middle-term mortality rates in
patients surviving an ACS and about comparison with mortality rates in the
corresponding healthy population. Our aims were: 1/to review the sex differ-
ence mortality at short-term (28 day) in ACS patients, 2/to describe short-term
mortality in relation with middle-term mortality (4 years), 3/to compare sex
difference of middle-term mortality in patients surviving an ACS with the cor-
responding population. 6022 patients hospitalized for a first ACS registered in
the Strasbourg (BR), Lille and Toulouse (HG) MONICA registries, between
2009 and 2011 were included. ACS were defined as STEMI, NSTEMI, or
unstable angina (UA). Mean follow-up was 50.3 months. 3025 patients
(50.2%) were STEMI, 1571 (26.1%) NSTEMI and 1426 (23.6%) UA. 
Short-term mortality was 6.7% in men vs 9.0% in women for STEMI
(p=0.05), 4.7% vs 4.2% for NSTEMI (p=0.67) and 5.2% vs 6.6% for UA
(p=0.29). Middle-term mortality was 7.4% in men and 8.5% in women for
STEMI (p=0.39), 11.5% vs 11.9% for NSTEMI (p=0.82) and 8.6% vs 10.9%
for UA (p=0.20). The small higher short-term and middle-term mortality in
women was removed after adjustment for age and center. In men the middle-
term risk of death for STEMI compared with the corresponding population was
3.05 [2.32-4.02] in HG, 2.88 [2.25-3.68] in BR and 2.34 [1.83-2.99] in Lille. In
women the risk of death was 6.80 [4.03-11.5], 5.04 [3.04-8.37] and 6.40 [4.28-
9.58] in HG, BR and Lille respectively. Considering males and females together,
middle-term mortality of STEMI for HG was in relation to the regional popula-
tion 3.26 [2.56-4.15] and to the French population 4.17 [3.27-5.32], for BR 3.53
[2.83-4.41] vs 3.74 [6.00-4.67] and for Lille 4.40 [3.57-5.43] vs 3.42 [2.78-
4.22]. Short-term and middle-term mortality were similar in men and women. In
patients surviving an ACS, middle-term mortality was, comparatively to the cor-
responding population, from 2 to 3 times higher in women than in men.
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The “Charlie Hebdo attack” in the morning of 7 January 2015 opened a
3 days series of terror attacks across Paris region. As France pays homage
to victims, local media dedicated a too large part of their programming to a
meticulouse coverage of the attacks. We retrospectively analized the activity
of our Chest Pain Unit during January 2015 in Toulouse (France) hypothe-
sizing that emotional stress could have triggered increased rate of cardiovas-
cular–related admission. In January 2015 a total of 346 patients were
referred to our Chest Pain Unit. Among them, 162 where hospitalized and
spent at least one night in hospital; 184 were discharged, we excluded car-
diovascular etiologies for their chest pain. We observed a higher rate of hos-
pitalizations when comparing the three days of attaks (7-9/01/15) with rate
of admission for the whole month of January 2015 and 2014. During these
3 days, the incidence of daily admission for cardiovascular events requiring
hospitalization raised by more than 75% (4.85 vs 8,67; p=0.0025; +78.4%;
IC95% 1.44-6.15) if compared with the daily rate for the rest of January
2015. We obtained similar data when comparing rate of daily hospitaliza-
tions with the same week-days of the following week (3.67 vs 8,67;
p=0.0061; +136.2%; IC95%=2.38-7.62), or also the year before at the same
time (year 2014). We observed a significant decrease 3 days after the attacks
(From 8.67 to 4.67; p=0.0058; –46.1%; IC95%=1.77-6.23). Furthermore we
analysed more specifically cardiovascular causes and we observed a signif-
icant increase in comparison with the whole month of january of the inci-
dence of STEMI (+180%, p=0,029), NSTEMI (+60,9%, p=0,014;),
symptomatic cardiac arrhythmias (+71,9%, p=0,027;), and of heart failure
(+86,7%, p=0,035;). Our data provides the evidence that a high stressful
experience as a terrorist attack intensively relayed by the media induces sig-
nificant admission for chest pain leading to hospitalisation for cardiovas-
cular events.
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Background A sizeable proportion of patients treated with PCI are unable
to take dual antiplatelet therapy (DAPT) for the guideline-recommended
time period of 6-12 months. Optimal treatment of pts at high bleeding risk
thus remains uncertain. The BioFreedom™ DCS (Biosensors, Europe SA,
Abstract 0112 – Table: Evolution of outcomes from 1995 to 2010 across age 
groups
<75 years (n=7.221)
1995-2000-2005-2010
75 years (n=3.389)
1995-2000-2005-2010
VF 4.0 – 2.3 – 1.5 – 1.2% 4.6 – 4.9 – 2.0 – 1.0%
AF 7.7 – 5.0 – 3.7 – 2.9% 21.5 – 16.8 – 9.5 – 10.1%
Reinfarction NA – 2.3 – 1.5 – 0.8% NA – 2.9 – 2.4 – 1.8%
Stroke NA – 0.7 – 0.7 – 0.4% NA – 1.6 – 1.4 – 0.5%
Shock 4.7 – 4.4 – 4.0 – 2.7% 11.6 – 13.6 – 9.3 – 6.7%
30-day death 7.2 – 4.8 – 2.9 – 1.4% 25.0 – 16.8 – 13.0 – 8.4%
One-year death 10.9 – 8.8 – 5.9 – 3.9% 36.2 – 30.0 – 26.9 – 
20 0%
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Morges, Switzerland) is polymer- and carrier-free, releases Biolimus A9 into
the vessel wall over a period of 4 weeks, and then technically becomes a
BMS.
Methods 2,466 pts at high bleeding risk from 68 centers in Europe,
Asia, and Canada were enrolled over an 18 months period in a double-
blinded randomized 1:1 comparison of the Gazelle™ BMS vs. the BioF-
reedom DCS (both Biosensors, Morges, CH) with a 1 month course of
DAPT only in both arms. At 1 year, the primary endpoints are: safety: a
composite of cardiovascular death, MI and stent thrombosis, and efficacy:
the rate of ci-TLR. 
Current results In the trial population, the most frequently used inclu-
sion criteria were: advanced age (64%), need for long term oral anticoag-
ulation (36%), anemia, recent bleeding or transfusion (20%), renal
insufficiency (18%), planned surgery (15%) and concomitant cancer (9%).
When compared to those included in ‘all-comer’ trials, pts were markedly
older (75 years) and had more co-morbidiites (diabetes 33%, atrial fibril-
lation 33%, peripheral vascular disease 15%, heart failure 13%, prior
stroke 9% and COPD 11%) 1.5 lesions/pts were treated and 1.7 stents/pts
were implanted for a total stent length of 32mm/patient. Technical proce-
dure success was 95%. 71% of pts were discharged on DAPT alone, 27%
of DAPT+oral anticoagulation and 2% on a single antiplatelet agent + oral
anticoagulation.
Conclusion The trial focuses on a never previously studied high bleeding
risk population characterized by advanced age and more comorbid conditions.
It is the 1st evaluation of a DCS with clinical endpoints and comprises the
shortest ever DAPT course with an active stent to be evaluated for both safety
and efficacy.
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Despite the recent improvements in percutaneous coronary intervention
(PCI), angiographically visible distal embolization (AVDE) complicates 6 to
18% of ST elevation myocardial infarction (STEMI) treated with PCI, and
is associated with poor clinical outcomes. Culprit lesion characteristics have
been proved to be the main predictive factor of AVDE. But data regarding
clinical characteristics predicting AVDE are lacking. We aimed to identify
predictors of AVDE complicating PCI in STEMI management. 769 consec-
utive patients admitted for STEMI who underwent PCI were included. Clin-
ical, angiographic and therapeutics characteristics were assessed for each
patien. AVDE was defined as an abrupt vessel closure occurring at any point
during the PCI procedure and that was not present at baseline. Thrombec-
tomy was used only when thrombolysis in myocardial infarction flow was
≤2. AVDE occurred in 112 (14.5%) patients. Patients with AVDE were
older (67±14 vs. 63±14; with p=0.010), less likely to be men (59 vs. 74%;
with p=0.002), have more frequently an artery diameter >3mm (36 vs. 28%:
with p=0.046), a right coronary artery culprit lesion site (59 vs. 37%; with
p<0.001) and more frequent thrombectomy (53 vs. 43%, with p=0.045).
There was no difference regarding the other cardiovascular risk factors nei-
ther regarding syntax score. By multivariate analysis, age>60 (OR[95% CI]:
1.69 (1.09-2.64); p=0.020), female gender (OR[95% CI]:1.71(1.09-2.70);
p=0.020), thrombectomy (OR[95% CI]:1.67(1.10-2.53); p=0.016) and the
right coronary artery culprit lesion site (OR[95% CI]:2.52(2.1.66-3.81);
p<0.001) were independent factors associated with AVDE. AVDE compli-
cating PCI in STEMI management is frequent (14.5%). Strikingly we found
no association between AVDE and culprit lesion characteristics. Conversely,
clinical characteristics as age (>60 year-old), female gender, thrombectomy
and the right coronary artery culprit lesion site are the most powerful pre-
dictive factors of AVDE.
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Background Percutaneous coronary interventions (PCIs) use significant
doses of ionizing radiation, especially when treating complex lesions. Ionizing
radiation may lead to adverse acute or delayed skin lesions in this setting, for
which the incidence is not well known.
Purpose To assess the incidence of radiation-induced skin lesions fol-
lowing PCI.
Methods We conducted a prospective, observational, single-centre study
on the incidence of radiation-induced skin lesions at 3-5 days (acute) and at 6
months (subacute) after PCI with a dose-area product (DAP) ≥200Gy.cm2,
between 1 January and 31 December 2013. Patients consenting to participate
were given information on potential skin lesions and were interviewed at 5-7
days and at 6 months after the PCI. 
Results 1168 PCIs were performed; the radiation dose was available for
937 patients. Of these, 102 underwent PCI with DAP≥200Gy.cm2. High body
mass index (BMI; OR 6.2, 95% CI 2.8-13.9) and elective (vs emergency) pro-
cedures (OR 2.0, 95% CI 1.1-3.4) were independently associated with DAP
≥200Gy.cm2. Three patients (3%, 95% CI 0.6-8.4) were diagnosed with acute
lesions (DAP of 485Gy.cm2, 205Gy.cm2, and 201Gy.cm2), two of whom also
presented with subacute lesions following PCI with DAP of 485Gy.cm2 (Fig.)
and 205Gy.cm2. One patient presented with a subacute lesion (DAP
280Gy.cm2) only. Four patients presented with a skin lesion, which represents
4% (95% CI 1.1-9.7) of patients with DAP ≥200Gy.cm2 and 0.4% (95% CI
0.1-1.1) of all the patients who underwent PCI, irrespective of DAP dose.
Conclusions The incidence of radiation-induced acute and subacute skin
lesions developing after PCI in this single-centre study was 4% in patients
with DAP ≥200Gy.cm2, with a total incidence of 0.4%. These data may sug-
gest the need for systematic assessment of skin lesions after high-dose radia-
tion PCI.
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Background Because of a presumably increased incidence of long-term
malignancy in interventional cardiologists, radiation exposure of the oper-
ator (ORE) during coronary interventions is of rising concern. A few studies
comparing femoral to radial or right to left radial access have been published,
but no data comparing the three access sites are available to our knowledge.
Purpose We sought to compare ORE by right femoral (RFA), right radial
(RRA) and left radial (LRA) access during percutaneous catheterization for diag-
nostic coronary angiography (CA) with or without coronary angioplasty (PCI).
Methods From September 2014 to February 2015, all consecutive patients
undergoing elective or emergency CA/PCI were prospectively included.
Selection of the access site was left to the discretion of the cardiologist. ORE
was measured using individual electronic radiation dosimeter badges posi-
tioned externally on the sternum. Radioprotection materials and equipment
was similar for all procedures. Primary endpoint was ORE quantified as
cumulative dose (CD) per dose-area product (DAP), in order to adjust for the
administered radiation dose.
